关于QbD驱动优化脂质纳米颗粒用于口服药物输送的审查:从框架到配方
Aulia Fikri Hidayat1,2, Yoga Windhu Wardhana3, Suwendar Suwendar2
1Doctoral Program of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
International journal of nanomedicine
|July 8, 2025
概括
设计质量 (QbD) 通过脂质纳米粒子 (LNPs) 提高了口服药物输送. QbD确保了一致的LNP质量,提高了药物的生物可用性,并实现了可扩展的生产.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 口服药物管理是首选的,但由于胃肠道障碍和新陈代谢而面临生物可用性挑战.
- 脂质纳米颗粒 (LNP),包括SLN和NLC,显示出改善口服药物稳定性,透性和吸收的潜力.
- 设计质量 (QbD) 框架为LNP开发和制造提供了一个系统的方法.
研究的目的:
- 审查通过设计质量 (QbD) 框架在开发脂质纳米颗粒 (LNPs) 用于口服药物输送中的应用.
- 突出QbD的关键元素及其在优化LNP配方和生产中的作用.
- 讨论关键材料属性 (CMA) 和关键过程参数 (CPP) 对LNP质量属性 (CQA) 的影响.
主要方法:
- 对QbD关键要素的审查:QTPP,CQA,CMA,CPP和DoE.
- 讨论CMA和CPP对LNP特征的影响 (粒子大小,PDI,EE,zeta潜力,药物释放).
- 优化LNP的体外,体内和体外表现的探索.
主要成果:
- QbD促进了基于科学的方法来制定LNP,确保产品质量的一致性.
- 了解和控制CMA和CPP对于实现所需的LNP CQA至关重要.
- 优化的LNP在各种体外,体内和体外模型中表现得更好.
结论:
- QbD框架为合理设计和可扩展制造高质量的基于脂质的药物递送系统提供了强大的策略,用于口服.
- 实施QbD原则可以提高流程理解,缩短开发时间,降低生产成本.
- QbD对于确保口服LNP的有效性和安全性至关重要.
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.


